课题基金 / 基金详情

Fhit Function in Human Cancer

Fhit Function in Human Cancer
Fhit 在人类癌症中的功能
批准号:
6570497
负责人:
KAY HUEBNER
金额:
$15.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2003-02-28

项目摘要

项目成果

KAY HUEBNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) One or both alleles of the FHIT gene are disrupted in a large fraction of many different types of human tumors. In tumor-derived cell lines and primary tumors with defined FHIT DNA alterations, there is a correlation between DNA alteration, detection of altered RT-PCR products and reduction in the level of Fhit protein. Additionally, replacement of Fhit expression in tumor cell lines suppresses tumorigenicity. This result has been confirmed by recent studies from another laboratory using an adenovirus/Fhit vector. Most recently, immunohistochemical studies of cervical, lung, gastric, bladder, pancreatic and kidney carcinomas have shown that large fractions of these primary tumors express reduced levels or no Fhit protein. This project will continue to study Fhit function by characterizing three possible Fhit, Nit or NitFhit interacting proteins identified from a D. melanogastor library using fly NitFhit as bait in yeast two-hybrid trapping experiments. The candidate interacting proteins are: 1) the c-terminus of the fly coracle protein, a homolog of mammalian 4.1 proteins; 2) a fatty acid binding protein homolog; 3) a fly polypeptide, Dcl5, without known homologs. The interactions will be confirmed in biochemical assays in fly or human systems. Each interaction pathway will then be dissected to understand its role in Fhit signaling. In parallel, Project 1 investigators will participate in characterization of deletions and arrangements of FHIT/FRA3B in specific cancer cells (with Project 2) and will prepare mutant Nit and Fhit proteins in the framework of structural predictions with Project 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy
  • 批准号:
    8304359
  • 项目类别:
  • 资助金额:
    $44.37万
  • 财政年份:
    2010
  • 负责人:
    KAY HUEBNER
  • 依托单位:
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy
  • 批准号:
    8207324
  • 项目类别:
  • 资助金额:
    $46.51万
  • 财政年份:
    2010
  • 负责人:
    KAY HUEBNER
  • 依托单位:
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy
  • 批准号:
    8535313
  • 项目类别:
  • 资助金额:
    $41.11万
  • 财政年份:
    2010
  • 负责人:
    KAY HUEBNER
  • 依托单位:
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapy
  • 批准号:
    8699693
  • 项目类别:
  • 资助金额:
    $39.45万
  • 财政年份:
    2010
  • 负责人:
    KAY HUEBNER
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: